These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19019390)

  • 1. Re: Prostate specific antigen working group guidelines on prostate specific antigen doubling time: P. M. Arlen, F. Bianco, W. L. Dahut, A. D'Amico, W. D. Figg, s. J. Freedland, J. L. Gulley, P. W. Kantoff, M. W. Kattan, A. Lee, M. M. Regan and O. Sartor J Urol 2008; 179: 2181-2186.
    Boyd CN
    J Urol; 2009 Jan; 181(1):411; author reply 411. PubMed ID: 19019390
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial: R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, f. Denardi and L. O. Reis J Urol 2010; 183: 940-945.
    Yoon DK; Park HS; Park JY
    J Urol; 2010 Nov; 184(5):2214-5; author reply 2215. PubMed ID: 20864135
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
    Wagner MD; Daneshmand S; Sokoloff M; Barry JM
    J Urol; 2007 Jun; 177(6):2396; author reply 2396-7. PubMed ID: 17509368
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: re: early detection of prostate cancer: AUA guideline: J. W. Moul, P. C. Walsh, M. S. Rendell, H. T. Lynch, S. W. Leslie, O. Kosoko-Lasaki, W. P. Fitzgibbons, I. Powell, A. V. D'Amico and W. J. Catalona J Urol 2013; 190: 1134-1139.
    Shah N; Ioffe V
    J Urol; 2014 Mar; 191(3):871. PubMed ID: 24355135
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265.
    Stenmark MH; Hamstra DA
    J Urol; 2012 Dec; 188(6):2438-9; author reply 2439-40. PubMed ID: 23088984
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Early detection of prostate cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, B. R. Konety, M. H. Murad, D. F. Penson and A. L. Zietman J Urol 2013; 190: 419-426.
    Moul JW; Walsh PC; Rendell MS; Lynch HT; Leslie SW; Kosoko-Lasaki O; Fitzgibbons WP; Powell I; D'Amico AV; Catalona WJ
    J Urol; 2013 Sep; 190(3):1134-7. PubMed ID: 23871525
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories: E. A. Klein, F. J. Bianco, A. M. Serio, J. A. Eastham, M. W. Kattan, J. E. Pontes, A. J. Vickers and P. T. Scardino J Urol 2008; 179: 2212-2217.
    Sivanandam A; Bhandari M
    J Urol; 2008 Dec; 180(6):2716-7; author reply 2717-8. PubMed ID: 18951589
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease: N. D. Arvold, M. H. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, L. L. Bañez, M. J. Katin, M. H. Braccioforte and A. V. D'Amico J Urol 2011; 186: 91-96.
    Trock BJ
    J Urol; 2012 Jan; 187(1):356; author reply 356-7. PubMed ID: 22119358
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population: D. P. Ankerst, R. Miyamoto, P. V. Nair, B. H. Pollock, I. M. Thompson and D. J. Parekh J Urol 2009; 181: 2071-2076.
    Hammond I; Bunting PS
    J Urol; 2010 Jan; 183(1):396. PubMed ID: 19926100
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. K. E. Hoffman, P. L. Nguyen, A. K. Ng and A. V. D'Amico. J Urol 2010; 183: 1798-1802.
    Neulander EZ
    J Urol; 2011 May; 185(5):1982; author reply 1983. PubMed ID: 21421243
    [No Abstract]   [Full Text] [Related]  

  • 13. In regard to D'Amico et al.: predictors of mortality after prostate-specific antigen failure (Int J Radiat Oncol Biol Phys 2006;65:656-660).
    Williams S
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1598; author reply 1598-9. PubMed ID: 17126225
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer when the Prostate Specific Antigen is in the Diagnostic Gray Zone: .: A. Aminsharifi, L. Howard, Y. Wu, A. De Hoedt, C. Bailey, S. J. Freedland and T. J. Polascik J Urol 2018; 200: 758-766.
    Wang CS; Jhan JH; Li CC
    J Urol; 2019 Mar; 201(3):627-628. PubMed ID: 30759714
    [No Abstract]   [Full Text] [Related]  

  • 15. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
    Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
    Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
    Walsh PC
    J Urol; 2009 Mar; 181(3):1499; author reply 1499-500. PubMed ID: 19157429
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
    Arlen PM; Bianco F; Dahut WL; D'Amico A; Figg WD; Freedland SJ; Gulley JL; Kantoff PW; Kattan MW; Lee A; Regan MM; Sartor O;
    J Urol; 2008 Jun; 179(6):2181-5; discussion 2185-6. PubMed ID: 18423743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Recent Changes in Prostate Cancer Screening Practices and Epidemiology: D. J. Lee, K. Mallin, A. J. Graves, S. S. Chang, D. F. Penson, M. J. Resnick and D. A. Barocas J Urol 2017;198:1230-1240.
    Patel N; Hu JC
    J Urol; 2018 Jun; 199(6):1633-1634. PubMed ID: 29555543
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Monique J. Roobol, Ewout W. Steyerberg, Ries Kranse, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010;57:79-85.
    Morrod D
    Eur Urol; 2010 Sep; 58(3):327; author reply 328-30. PubMed ID: 20598799
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. I. F. San Francisco, M. M. Regan, W. C. DeWolf and A. F. Olumi, J Urol, 175: 1341-1346, 2006.
    Morales A
    J Urol; 2006 Dec; 176(6 Pt 1):2746; author reply 2746. PubMed ID: 17085212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.